What iTAP Offers

The Immunome Technology Accesss Program (iTAP) is primarily targeted at pharmaceutical and biotechnology companies to rapidly enhance and grow their biomarker, drug and diagnostic discovery portfolios in a deep collaborative fashion by fully leveraging Sengenics’ Immunome protein array technology.